Loading company…
| Award | Agency | Industry (NAICS) | Obligated (USD) | Signed |
|---|---|---|---|---|
| 75D30126P21454 on USAspending.gov (opens in a new tab) | Centers for Disease Control and Prevention | 325413 in-vitro diagnostic substance manufacturing | $356,500 | 2026-09-02 |
| 75D30126P21277 on USAspending.gov (opens in a new tab) | Centers for Disease Control and Prevention | 541714 research and development in biotechnology (except nanobiotechnology) | $170,680 | 2026-08-28 |
| 75D30126P21238 on USAspending.gov (opens in a new tab) | Centers for Disease Control and Prevention | 541714 research and development in biotechnology (except nanobiotechnology) | $234,000 | 2026-08-19 |